Thiotepa/Busulfan/Cyclophosphamide versus Busulfan/Thiotepa Conditioning For Autologous Stem Cell Transplantation in CNS Lymphoma: A Single-Center Comparative and Descriptive Experience.
A modified stem cell transplant regimen for brain lymphoma caused less severe mouth damage than standard treatment while controlling disease similarly.
This retrospective single-center comparative cohort study examined Thiotepa/Busulfan/Cyclophosphamide versus Busulfan/Thiotepa Conditioning For Autologous Stem Cell Transplantation in CNS Lymphoma: A Single-Center Comparative and Descriptive Experience. BuTT conditioning showed similar early disease control to TBC with less grade 3-4 mucositis and no non-relapse deaths in this small, nonrandomized cohort.
What the study was
- Study design
- Retrospective single-center comparative cohort study
- Sample size
- 18
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Transplantation and cellular therapy
Why it surfaced
Retained after review of PubMed metadata and abstract because its retrospective single-center comparative cohort study directly informs hematologic malignancies; scoring was capped conservatively for design and evidence maturity.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.